Assessment of AmpC Beta-Lactamase Genes among Clinical Escherichia coli Isolates
AbstractBackground: AmpC beta lactamases play a significant role in creating resistance to third generation cephalosporins worldwide. They mostly express on chromosome of Enterobacteriaceae especially Escherichia coli and cause consequential problem in clinical treatment and lead to failure in diagnosis and phenotypic test recommended by Clinical and Laboratory Standards Institute. Methods: Totally 200 E. coli isolates from different hospitals of Tehran were collected. The isolates were screened by disk diffusion method according to the CLSI guidelines. The profiles and prevalence surveys of AmpC (Dha, CITM, Mox and FOX-type) β-lactamase genes in clinical isolates of E. coli by phenotypic and molecular methods. Results: Out of 200 E. coli isolated, 115 (89.8%) and 13 (10.2%) isolates were identified as ESBL- and AmpC- beta-lactamase producers, respectively. Among AmpC producers, 13 (100%) and 5 (38.5%) isolates was reported by PCR assay as blaCITM and Dha, respectively. Mox and FOX genes were not detected in any sample.Conclusion: Our results highlight the importance of using molecular detection methods to identify β-lactamase-producer that have resistance to antibiotics.
Mulvey MR, Simor AE. Antimicrobial resistance in hospitals: how concerned should we be? CMAJ. 2009 Feb 17; 180(4):408-15.
Mendonc N¸ Manageiro V, Robin F, et al. The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition. Antimicrob Agents Chemother 2008; 52(5): 1806-1811.
Silva J, Agullar C, Ayala G, et al. TLA-1: a new plasmid-mediated extended-spectrum β-lactamase from Escherichia coli. Antimicrob Agents Chemother 2000; 44(4): 997-1003.
Emery CL and Weymouth LA. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35: 2061-2067.
Polsfuss S, Bloemberg GV, Giger J, et al. Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing Enterobacteriaceae. J Clin Microbiol 2011; 49(8): 2798-2803.
Kiratisin P, Apisarnthanarak A, Laesripa C. et al. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase Producing Escherichia coli and Klebsiella pneumonia isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 2008; 52(8): 2818-2824.
Rubin JE, Pitout J D.D. Extended-spectrum β-lactamase, carbapenemase and AmpC producng Enterobacteriaceae in companion animals. Vet Microbiol 2014; 170: 10-18.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement 25 (1).
Goossens H & Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase and AmpC-producing Enterobacteriaceae from the MYSTIC program in Europe and the United States (1997–2004). Diagnostic Microbiol Infect Dis 2005; 53: 257-264.
Deshpande LM, Jones RN, Fritsche TR, et al. Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: report from the SENTRY antimicrobial surveillance program (North America, 2004). Inter J Antimicrob Agents 2005; 28: 578-581.
Pérez-Pérez FJ & Hanson ND. Detection of plasmid-mediated AmpC β -lactamase genes in clinical isolates by using multiplex PCR. J of Clin Microbiol 2002; 40(6): 2153–2162
Jaurin B, Grundström T, Edlund T, et al. The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation. Nature 1981; 290(5803): 221-5.
Deshpande LM, Jones RN, Fritsche TR, et al. Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). Int J Antimicrob Agents 2006; 28: 578-58.
Song W, Bae K, Lee YN, et al. Detection of extended-spectrum β -lactamases by using Boronic acid as an AmpC β -lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007; 45(4): 1180-1184.
Walther-Rasmussen J and Hoity N. Plasmid-borne AmpC –lactamases. Can J Microbiol 2002; 48: 479-493.
Gharout AS, Touatib A, Guillardc T, et al. Molecular characterization and epidemiology of cefoxitin resistance among Enterobacteriaceae lacking inducible chromosomal AmpC genes from hospitalized and non-hospitalized patients in Algeria: description of new sequence type in Klebsiella pneumoniae isolates. Brazj Infect Dis 2015; 19(2): 187-195.
Pandey AD, Asthana AK, Rawat A, et al. Evaluation of phenotypic tests for the detection of AmpC beta-lactamase in clinical isolates of Escherichia coli. Indian J Pathol Microbiol 2013; 56: 135-138.
Hanson ND. AmpC β-lactamases: what do we need to know for the future? J Antimicrobial Chem 2003; 52, 2-4.
Hernandez-Alles S, Conejo M, Pascual A, et al. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chem 2000; 46: 273-277.
Coudron PE, Moland ES and Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000; 38(5): 1791-1796.
Polsfuss S, Poledica M, Hombach M, et al. Detection of AmpC Beta-lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic Analysis. J Clin Microbiol 2011; 49 (8): 2924-2932.
|Issue||Vol 4 No 3-4 (2015)|
|AmpC β-lactamase β-lactamase enzymes Escherichia coli Extended spectrum β-lactamase (ESBLs)|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|